Deliver Your News to the World

Epigenomics AG to Host Press Conference and Analyst Meeting for 2005 Annual Results


WEBWIRE –

Friday, 17.03.2006, Berlin, Germany and Seattle, WA, USA, Epigenomics AG (Frankfurt, Prime Standard: ECX), will hold a press conference and analyst meeting on March 24, 2006 to present results for the fiscal year 2005. Alexander Olek, CEO and Oliver Schacht, CFO will also give an overview of the operational developments as well as provide guidance for 2006.

Press Conference and Analyst Meeting
The press conference and analyst meeting will be conducted in German and will be held at 10am to 11am CET at Epigenomics’ premises in Berlin:

Epigenomics AG
Kleine Präsidentenstr. 1
10178 Berlin

Epigenomics asks interested parties to confirm their participation for the press conference and analyst meeting by Wednesday, March 22, 2006
by fax +49 (0)30 24345-555 or email ir@epigenomics.com

Conference Call and Webcast
A conference call and webcast will be held at 3pm CET (9am EST), hosted by Epigenomics’ management to discuss 2005 financial results and outlook for 2006. The conference call will be conducted in English.

Dial-in number (within the Germany.): +49 (0)69 58 999 0808
Dial-in number (outside the Germany): +1 480 629 9562

**Please dial-in at least 10 minutes prior to commencement of the conference call**

This call will also be available on the Web at: www.epigenomics.com
Corresponding presentation slides will be available for downloading in the investor relations section of Epigenomics’ website at: www.epigenomics.com/en/investor_relations/Corporate_Calendar/

About Epigenomics
Epigenomics is a molecular diagnostic company with a focus on the development of novel products for cancer. By detecting and interpreting DNA methylation patterns, Epigenomics’ tests can potentially diagnose disease at an early stage and help guide physicians to select an appropriate therapy. Epigenomics collaborates with Roche Diagnostics on the development of several diagnostic products in cancer. The company has its headquarters in Berlin, Germany, and a wholly owned subsidiary in Seattle, USA. For more information, please visit our website at www.epigenomics.com.

WebWireID11195





This news content was configured by WebWire editorial staff. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.